Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for Product Quality Review (PQR) Preparation – V 2.0

Posted on By

API Manufacturing: SOP for Product Quality Review (PQR) Preparation – V 2.0

Standard Operating Procedure for Product Quality Review (PQR) Preparation in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/165/2025
Supersedes SOP/API/165/2022
Page No. Page 1 of 12
Issue Date 14/04/2025
Effective Date 16/04/2025
Review Date 14/04/2026

1. Purpose

To establish a standard procedure for the preparation and review of Product Quality Reviews (PQRs) for all manufactured Active Pharmaceutical Ingredients (APIs), as per cGMP and regulatory requirements, to ensure consistency of the manufacturing process and continual product quality improvement.

2. Scope

This SOP applies to the Quality Assurance (QA) department responsible for the annual compilation of PQRs for each

commercial API product manufactured within the facility.

3. Responsibilities

  • QA Officer: Gather and compile data from respective departments.
  • Production, QC, Warehouse Heads: Provide relevant batch data, deviations, OOS, trends, and complaints.
  • Regulatory Affairs: Review for impact on product filings and variation requirements.
  • QA Head: Review and approve the final PQR report and trend analysis.
See also  API Manufacturing: SOP for Use of Barcode System in Material Management - V 2.0

4. Accountability

The Head of Quality Assurance is accountable for ensuring timely preparation, completeness, accuracy, and approval of PQRs as per regulatory compliance.

5. Procedure

5.1 PQR Frequency and Planning

  1. PQRs must be prepared:
    • Annually for each API manufactured
    • Within 90 days after calendar year-end
  2. QA shall prepare a PQR Calendar for the year (Annexure-1) and track status.

5.2 Information to be Included in PQR

  1. Product Overview:
    • Product name and strength
    • Manufacturing license or market authorization number
    • Specifications and approved shelf life
  2. Batch Manufacturing Data:
    • Total number of batches manufactured, rejected, and released
    • Yield data and process consistency trends
  3. Deviations and OOS:
    • Batch-specific and cumulative deviation data
    • Investigation summary and CAPAs
  4. Stability Study Results:
    • Annual stability data review
    • Out-of-trend results
  5. Complaints:
    • Product quality complaints and status
    • Market recalls (if any)
  6. Analytical Data Trends:
    • Review of specifications, test methods, and significant changes
  7. Regulatory Changes:
    • Change control or variations submitted to regulatory agencies

5.3 Data Collection and Compilation

  1. QA sends PQR Data Request Forms (Annexure-2) to Production, QC, Warehouse, Regulatory, and Engineering departments.
  2. All supporting documents and data must be submitted within 15 working days.
  3. QA compiles the PQR in the standardized template (Annexure-3).
See also  API Manufacturing: SOP for Preparation and Storage of Working Standards - V 2.0

5.4 Trend Analysis and Review

  1. Graphical representations of trends shall be included for:
    • Yield
    • Deviations per batch
    • OOS/OOT incidents
    • Complaints frequency
  2. Root cause evaluation and recommendations shall be documented.
  3. QA shall propose CAPAs or changes if trends show negative product or process impact.

5.5 PQR Approval and Archival

  1. Final compiled report shall be reviewed and signed by:
    • QA Head
    • Production Head
    • Regulatory Affairs (if needed)
  2. One soft copy and one hard copy shall be archived in the QA records room for 5 years.
  3. Electronic versions shall be stored on validated servers with version control.

5.6 CAPA and Follow-up Actions

  1. All recommendations from the PQR shall be tracked and implemented through CAPA management.
  2. QA shall ensure that proposed changes, validations, or process improvements are captured in the Change Control System.

6. Abbreviations

  • PQR: Product Quality Review
  • QA: Quality Assurance
  • QC: Quality Control
  • OOS: Out of Specification
  • OOT: Out of Trend
  • CAPA: Corrective and Preventive Action

See also  API Manufacturing: SOP for Safety Measures in Solvent Recovery Operations - V 2.0

7. Documents

  1. PQR Calendar (Annexure-1)
  2. PQR Data Request Form (Annexure-2)
  3. PQR Template Format (Annexure-3)
  4. CAPA Tracker and Closure Sheet

8. References

  • ICH Q7 – GMP for Active Pharmaceutical Ingredients
  • EU GMP Part II Section 2.3 – Product Quality Review
  • 21 CFR Part 211.180(e) – Annual Product Review

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: PQR Calendar

API Name Year PQR Due Date Status
Paracetamol 2024 31/03/2025 In Progress

Annexure-2: PQR Data Request Form

Department Data Requested Due Date Submitted On
Production Batch yield summary 20/01/2025 18/01/2025

Annexure-3: PQR Template Format

Section Description
1 Product Information
2 Batch Summary and Yield Trends
3 Deviation and OOS Summary
4 Stability Review
5 Complaint and Recall History
6 Analytical Trend Evaluation
7 Regulatory Filing Impact
8 CAPA Summary

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Release New SOP QA Head
14/04/2025 2.0 Updated structure and annexures GMP Alignment QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: BA-BE Studies: SOP for Short-Term Stability of Analyte – V 2.0
Next Post: Gel Manufacturing: SOP for Cleaning Validation of Gel Manufacturing Equipment – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version